Boerhaavia diffusa L. Attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-κβ and transforming growth factor β1

British Journal of Nutrition

Volumn 110, Issue 7, 2013, Pages 1201-1210

  Prathapan, A ^a   Vineetha, V P ^a   Abhilash, P A ^b   Raghu, K G ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

^b UNIVERSITY OF KERALA   (India)

Author keywords

Atrial natriuretic peptide; Boerhaavia diffusa; Cardiac hypertrophy; Reactive oxygen species; Transcription factors; Xanthine oxidase

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; BOERHAAVIA DIFFUSA EXTRACT; BRAIN NATRIURETIC PEPTIDE; CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; BOERHAVIA DIFFUSA; CELL LEVEL; CELL SIZE; CELL VIABILITY; CELL VOLUME; CELLULAR SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; EMBRYO; ENZYME ACTIVITY; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; LIPID PEROXIDATION; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CELL LINE; DOWN-REGULATION; GLUTATHIONE; HYPERTROPHY; LIPID PEROXIDATION; MYOBLASTS, CARDIAC; MYOCARDIUM; NF-KAPPA B; NYCTAGINACEAE; OXIDATIVE STRESS; PLANT EXTRACTS; PROTEIN CARBONYLATION; RATS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84884626931     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513000561     Document Type: Article

References (70)

1. Drazner MH, Rame JE, Marino EK, et al. (2004) Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 43, 2207-2215
2. Liu CJ, Cheng YC, Lee KW, et al. (2008) Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signalling pathway in H9c2 myocardiac cells. Mol Cell Biochem 313, 167-178
3. Papparella I, Ceolotto G, Montemurro D, et al. (2008) Green tea attenuates angiotensin II induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/Epidermal growth factor receptor/Akt signalling pathway. J Nutr 138, 1596-1601
4. Yao FR, Sun CW &Chang SK (2010) Morton lentil extract attenuated angiotensin II induced cardiomyocyte hypertrophy via inhibition of intracellular reactive oxygen species levels in vitro. J Agric Food Chem 58, 10382-10388
5. Takimoto E &Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodelling. Hypertension 49, 241-248
6. Li HL, Wang AB, Huang Y, et al. (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signalling transduction pathways. Free Rad Biol Med 38, 243-257
7. Alissa EM &Ferns GA (2012) Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J Nutr Metabol 2012, article ID 569486
8. Ames MK, Shigenaga MK &Hagen TM (1993) Oxidants, antioxidants and the degenerative disease of aging. Proc Natl Acad Sci U S A 90, 7915-7922
9. Stampfer MJ, Hu FB, Manson JE, et al. (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. New Eng J Med 343, 16-22
10. Kaur M &Goel RK (2011) Anti-convulsant activity of Boerhaavia diffusa: plausible role of calcium channel antagonism. Evid Based Complement Alternat Med 4, 1-7
11. Srivastava R, Saluja D, Dwarakanath BS, et al. (2011) Inhibition of human cervical cancer cell growth by ethanolic extract of Boerhaavia diffusa Linn. (Punarnava) root. Evid Based Complement Alternat Med 2011, article ID 427031
12. Apu AS, Liza MS, Jamaluddin ATM, et al. (2012) Phytochemical screening and in vitro bioactivities of the extracts of aerial part of Boerhaavia diffusa Linn. Asian Paci J Trop Biomed 2, 673-678
13. Munasinghe TCJ, Seneviratne CK, Thabrew IM, et al. (2001) Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytother Res 15, 519-523
14. Agrawal M, Nandini D, Sharma V, et al. (2010) Herbal remedies for the treatment of hypertension. Int J Pharm Sci and Res 1, 1-21
15. Pari L &Satheesh AM (2004) Antidiabetic effect of Boerhaavia diffusa: effect on serum and tissue lipids in experimental diabetes. J Med Food 7, 472-476
16. Manu KA &Kuttan G (2009) Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 31, 377-387
17. Sreeja S &Sreeja S (2009) An in vitro study on antiproliferative and antiestrogenic effects of Boerhaavia diffusa L. extracts. J Ethnopharmacol 126, 221-225
18. Aviello G, Canadanovic-Brunet JM, Milic N, et al. (2011) Potent antioxidant and genoprotective effects of Boeravinone G, a rotenoid isolated from Boerhaavia diffusa. Plos One 6, e19628
19. Prathapan A, Singh MK, Anusree SS, et al. (2011) Antiperoxidative, free radical scavenging and metal chelating activities of Boerhaavia diffusa L. J Food Biochem 35, 1548-1554
20. Gulati V, Harding IH &Palombo EA (2012) Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Compl Alt Med 12, 77
21. Pareta SK, Patra KC, Mazumder PM, et al. (2011) Aqueous extract of Boerhaavia diffusa root ameliorates ethylene glycol-induced hyperoxaluric oxidative stress and renal injury in rat kidney. Pharm Biol 49, 1224-1233
22. Singleton VL &Rossi JA (1965) Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Viticult 16, 144-158
23. Jia Z, Mengcheng T &Wu J (1999) The determination of flavanoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 64, 555-559
24. Hernandez-Ledesma B, Martin-Alvarez PJ &Pueyo E (2003) Assessment of the spectrometric method for determination of angiotensin-converting enzyme activity: influence of the inhibition type. J Agri Food Chem 51, 4175-4179
25. Owen PL &Johns T (1999) Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J Ethnopharmacol 64, 149-160
26. Wilson AP (2000) Cytotoxicity and viability assays. In Animal Cell Culture: A Practical Approach, 2nd ed., pp 175-219 [JRW Masters, editor]. Oxford: Oxford University Press
27. Merten KE, Jiang Y, Feng W, et al. (2006) Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. J Pharmacol Exp Therap 319, 934-940
28. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal Biochem 72, 248
29. Aebi H (1984) Catalase in vitro. Methods Enzymol 105, 121-127
30. Paoletti F, Aldinucci D, Mocali A, et al. (1986) A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154, 538-541
31. Gunzler WA, Kramers H &Flohe L (1974) An improved coupled test procedure for glutathione peroxidase. Klin Chem Klin Biochem 12, 444-448
32. Goldberg DM &Spooner RJ (1987) Glutathione reductase. In Methods of Enzymatic Analysis, pp 258-265 [HV Bergmeyer, editor]. Weinheim: Verlag-Chemie
33. Hissin PJ &Hilf RA (1976) Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214-226
34. Choi EH, Chang HJ, Cho JY, et al. (2007) Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol 45, 1873-1881
35. Raghu KG &Cherian OL (2009) Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes. J Trace Elem Med Biol 23, 61-68
36. Chomczynski P &Sacchi N (1987) Singlet-step method of RNA isolation by acid guanidium thiocyanate-phenol- chloroform extraction Anal Biochem 162, 156-159
37. Kimes BW &Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98, 367-381
38. Watkins SJ, Borthwick GM &Arthur HM (2011) The H9c2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In vitro Cell Dev Biol Animal 47, 125-131
39. Hescheler J, Meyer R, Plant S, et al. (1991) Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69, 1476-1486
40. Sipido KR &Marban E (1991) L-type calcium channels, potassium channels, and novel nonspecific cation channels in a clonal muscle cell line derived from embryonic rat ventricle. Circ Res 69, 1487-1499
41. Wollert KC &Drexler H (1999) The rennin-angiotensin system and experimental heart failure Cardiovasc Res 43, 838-849
42. Unger T (2002) The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89, 3A-9A
43. Wang H &Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Rad Biol Med 27, 612-616
44. Hajjar RJ &Leopold JA (2006) Xanthine oxidase inhibition and heart failure. Circ Res 98, 169-171
45. Poljsak B (2011) Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011, 194586
46. Dinu D, Bodea GO, Ceapa CD, et al. (2011) Adapted response of the antioxidant defense system to oxidative stress induced by deoxynivalenol in Hek-293 cells. Toxicon 57, 1027-1032
47. Devasagayam TPA, Boloor KK &Ramasarma T (2003) Methods for estimating lipid peroxidation: an analysis of merits and demerits. Ind J Biochem Biophys 40, 300-308
48. Nelson SK, Bose SK &McCord JM (1994) The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 16, 195-200
49. Shlafer M &Shepard BM (1984) A method to reduce interference by sucrose in the detection of thiobarbituric acid-reactive substances. Anal Biochem 137, 269-276
50. Halliwell B (1996) Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 25, 57-74
51. Peng X &Li Y (2002) Induction of cellular glutathione linked enzymes and catalase by the unique chemo preventive agent, 3H-1,2-dithiole-3-thione in rat cardiomyocytes affords protection against oxidative cell injury. Pharmacol Res 45, 491-497
52. Abhilash PA, Harikrishnan R &Indira M (2012) Ascorbic acid supplementation causes faster restoration of reduced glutathione content in the regression of alcohol induced hepatotoxicity in male guinea pigs. Redox Rep 17, 72-79
53. Kent KD, Harper WJ &Bomser JA (2003) Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol in vitro 17, 27-33
54. Ouyang X, Takahashi K, Komatsu K, et al. (2001) Protective effect of Salvia militiorrhiza on angiotensin II inducedhypertrophic responses in neonatal rat cardiac cells. Jpn J Pharmacol 87, 289-296
55. Ichikawa H, Yagi H, Tanaka T, et al. (2010) Lagerstroemia speciosa extract inhibit TNF-induced activation of nuclear factor-kb in rat cardiomyocyte H9c2 cells. J Ethnopharmacol 128, 254-256
56. Purcell NH, Tang G, Yu C, et al. (2001) Activation of NF-kb is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98, 6668-6673
57. Li Y, Ha T, Gao X, et al. (2004) NF-kB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 287, 1712-1720
58. Baldwin AS Jr (1996) The NF-kappa B and I-kappa B proteins: new discoveries and insights. Ann Rev Immunol 14, 649-683
59. Jones WK, Brown M, Wilhide M, et al. (2005) NF kb in cardiovascular disease. Cardiovasc Toxicol 5, 183-201
60. Li RK, Li G, Mickle DA, et al. (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96, 874-881
61. Schultz JJ, Witt SA, Glascock BJ, et al. (2002) TGF-b1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109, 787-796
62. Yamazaki T, Yamashita N, Izumi Y, et al. (2012) The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice. Hypertension Res 35, 34-40
63. Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81, 292-297
64. Ferreres F, Sousa C, Justin M, et al. (2005) Characterization of phenolic profile of Boerhaavia diffusa L. by HPLC-PAD-MS/ MS as tool for quality control. Phytochem Anal 16, 451-458
65. Vineetha VP, Prathapan A, Soumya RS, et al. (2012) Arsenic trioxide toxicity in H9c2 myoblasts - damage to cell organelles and possible amelioration with Boerhaavia diffusa. Cardiovasc Toxicol (Epublication ahead of print version 19 November 2012)
66. Perez-Vizcaino F &Duarte J (2010) Flavonols and cardiovascular disease. Mol Aspects Med 31, 478-494
67. Duarte J, Jimenez R, O'Valle F, et al. (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 20, 1843-1854
68. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, et al. (2011) A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11, 298-344
69. Senthil S, Sridevi M &Pugalendi KV (2007) Protective effect of ursolic acid against myocardial ischemia induced by isoproterenol in rats. Toxicol Mech Methods 17, 57-65
70. Lami N, Kadota S, Kikuchi T, et al. (1991) Constituents of the roots of Boerhaavia diffusa L. III. Identification of a calcium channel antagonistic compound from the methanol extract. Chem Pharm Bull 39, 1551-1555.